Image courtesy Cognision
Cognision is a Louisville-based biotech company led by David Richardson (formerly of RentalHouses.com and The Learning House). The company has created an FDA-cleared, web-enabled portable headset system--COGNISION®--that is used to identify and evaluate cognitive signals in the brain.
Louisville Future spoke with Chief Technology Officer and Founder KC Fadem about how the company came to be and the advantages of the tech.
Tell us about COGNISION®.
Fadem: We have created a device that records brain activity while the person is performing a cognitive task.
We can then evaluate that data and determine whether or not these people have some kind of neurological disorder such as Alzheimer’s disease, MTBI, (mild traumatic brain injury), or schizophrenia.
We can use these kinds of measures in studies determining what kind of drugs to use to treat these neurological disorders.
How did the company come about?
Fadem: We started the company based on some research that was going on at the University of Louisville. We knew we could take that academic exercise and commercialize it.
Dr. John Barker and I were partners in a medical incubator at the time at UofL. We learned about the concepts there and we built the technology and the products themselves. We did a few years of clinical studies starting in 2011, and we got the device cleared by the FDA in 2015.